Save Daliresp for SEVERE COPD Patients With Frequent Exacerbations
New data will help clarify when to use Daliresp (roflumilast) to prevent COPD exacerbations.
You may hear that Daliresp decreases hospitalizations due to COPD exacerbations by 25%. This works out to one fewer hospitalization for every 24 severe COPD patients on Daliresp for a year.
Continue to maximize bronchodilators and inhaled steroids first. Ensure that patients are using their inhalers properly and consistently.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote